@article{gravis:inserm-02092595,
  TITLE = {{Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies}},
  AUTHOR = {Gravis, Gwena{\"e}lle and Boher, Jean-Marie and Chen, Yu-Hui and Liu, Glenn and Fizazi, Karim and Carducci, Michael and Oudard, Stephane and Joly, Florence and Jarrard, David and Souli{\'e}, Michel and Eisenberger, Mario and Habibian, Muriel and Dreicer, Robert and Garcia, Jorge and Hussain, Maha and Kohli, Manish and Vogelzang, Nicholas and Picus, Joel and Dipaola, Robert and Sweeney, Christopher},
  URL = {https://inserm.hal.science/inserm-02092595},
  JOURNAL = {{European Urology}},
  PUBLISHER = {{Elsevier}},
  VOLUME = {73},
  NUMBER = {6},
  PAGES = {847-855},
  YEAR = {2018},
  MONTH = Jun,
  DOI = {10.1016/j.eururo.2018.02.001},
  KEYWORDS = {Androgen deprivation therapy ; Chemotherapy ; Docetaxel ; High volume ; Low volume ; Metastatic castrate naive prostate cancer ; Metastatic prostate cancer ; Prostate cancer ; Volume disease},
  HAL_ID = {inserm-02092595},
  HAL_VERSION = {v1},
}